Although the CathA−/− knockout mouse model presents phenotypes similar to human patients with galactosialidosis, severe symptoms arising due to the secondary deficiency of Neu1 and β-Gal prevent the use of this mouse model for behavioral analysis [9]. This evidence concerns the gene NEU1 and galactosialidosis.